Researchers Reveal Racial Disparities in Access to Remdesivir for Patients With Cancer and COVID-19
Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.
Randi Hernandez
Editor
Randi Hernandez is the oncology editor for Cancer Therapy Advisor. Randi has extensive experience in health care reporting and a particular interest in how medications shape the lives of patients and how treatments evolve, tracking them from scientific theory to clinical development, manufacturing stages, market release, and postmarketing studies. Prior to joining Haymarket, Randi held editing and/or writing roles at Pharmacy Times and Specialty Pharmacy Times, BioPharm International and Pharmaceutical Technology, Genetic Engineering and Biotechnology News (GEN), and BioPharma Dive.
